O'Day Daniel Patrick's Form 4 filing
Gilead Sciences, Inc. (GILD) · filed Sep 30, 2025
- Accession no.
- 0001638643-25-000009
- Filed
- Sep 30, 2025
- Trade date
- Sep 29, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $1.12M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| O'Day Daniel PatrickCIK 0001638643 | Director, Officer (Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2025 | Common Stock | SSaleDisposed | −8,039 | $111.47 | −$896,107.33 | 593,164 | Direct | |
| Sep 29, 2025 | Common Stock | SSaleDisposed | −1,961 | $112.42 | −$220,455.62 | 591,203 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.